ANI Pharmaceuticals (NASDAQ:ANIP) Earns Buy Rating from HC Wainwright
ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $94.00 target price on the specialty pharmaceutical company’s stock. HC Wainwright’s target price suggests a potential upside of 46.37% from the stock’s previous […]
ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $94.00 target price on the specialty pharmaceutical company’s stock. HC Wainwright’s target price suggests a potential upside of 46.37% from the stock’s previous […]
